System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+909 today

System

Live1m

Terminal Asset View

stockNASDAQ

GOSS

$0.44-4.98%

Gossamer Bio Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

6Neutral

Live Analysis Active

Company Mission

Gossamer Bio Inc creates experimental medicines for people with severe lung diseases, such as asthma and pulmonary fibrosis. Doctors and patients use these drugs in clinical trials to test if they are safe and effective. The company makes money by partnering with larger pharmaceutical firms or selling the drugs if they get approval from health authorities.

GOS

Industry Context

This company operates in the biotech industry, which focuses on developing new medical treatments through scientific research. It targets serious diseases like lung conditions, where effective drugs are often in high demand. Success depends heavily on clinical trial results and regulatory approvals from agencies like the FDA.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

26Matrix

Market Momentum

21.7— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.2x— Normal Volume

Today's Change

-4.98%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing GOSS across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:34 AM UTC

As-of As of 2026-03-16T02:19:12.809Z UTC (~15m delay).

Develops new medicines for serious lung and blood diseases, aiming to earn revenue from drug sales if approved by regulators.

Technical patterns are forming near , suggesting bullish momentum as the price consolidates above recent lows. Watch for a breakout above $0.44.

Volume spiked 3x at $1, indicating buyer interest because it coincided with positive clinical trial news. Monitor if volume stays elevated above average.

Industry trends in biotech are driving strength, with price holding above $0.44, signaling resilience in a volatile sector. Watch for sector recovery and FDA decisions.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...